United States Iron Deficiency Anemia Drug Market Report 2017

United States Iron Deficiency Anemia Drug Market Report 2017

1 Iron Deficiency Anemia Drug Overview

1.1 Product Overview and Scope of Iron Deficiency Anemia Drug

1.2 Classification of Iron Deficiency Anemia Drug by Product Category

1.2.1 United States Iron Deficiency Anemia Drug Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Iron Deficiency Anemia Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Ferrous Sulfate (Feratab, Fer-Iron, Slow-FE)

1.2.4 Carbonyl Iron (Feosol)

1.2.5 Iron Dextran Complex (INFeD)

1.2.6 Iron Sucrose (Venofer)

1.2.7 Ferric Carboxymaltose (Injectafer)

1.3 United States Iron Deficiency Anemia Drug Market by Application/End Users

1.3.1 United States Iron Deficiency Anemia Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Children

1.3.3 Adult

1.3.4 The Old

1.4 United States Iron Deficiency Anemia Drug Market by Region

1.4.1 United States Iron Deficiency Anemia Drug Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Iron Deficiency Anemia Drug Status and Prospect (2012-2022)

1.4.3 Southwest Iron Deficiency Anemia Drug Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Iron Deficiency Anemia Drug Status and Prospect (2012-2022)

1.4.5 New England Iron Deficiency Anemia Drug Status and Prospect (2012-2022)

1.4.6 The South Iron Deficiency Anemia Drug Status and Prospect (2012-2022)

1.4.7 The Midwest Iron Deficiency Anemia Drug Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Iron Deficiency Anemia Drug (2012-2022)

1.5.1 United States Iron Deficiency Anemia Drug Sales and Growth Rate (2012-2022)

1.5.2 United States Iron Deficiency Anemia Drug Revenue and Growth Rate (2012-2022)

2 United States Iron Deficiency Anemia Drug Market Competition by Players/Suppliers

2.1 United States Iron Deficiency Anemia Drug Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Iron Deficiency Anemia Drug Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Iron Deficiency Anemia Drug Average Price by Players/Suppliers (2012-2017)

2.4 United States Iron Deficiency Anemia Drug Market Competitive Situation and Trends

2.4.1 United States Iron Deficiency Anemia Drug Market Concentration Rate

2.4.2 United States Iron Deficiency Anemia Drug Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Iron Deficiency Anemia Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Iron Deficiency Anemia Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Iron Deficiency Anemia Drug Sales and Market Share by Region (2012-2017)

3.2 United States Iron Deficiency Anemia Drug Revenue and Market Share by Region (2012-2017)

3.3 United States Iron Deficiency Anemia Drug Price by Region (2012-2017)

4 United States Iron Deficiency Anemia Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Iron Deficiency Anemia Drug Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Iron Deficiency Anemia Drug Revenue and Market Share by Type (2012-2017)

4.3 United States Iron Deficiency Anemia Drug Price by Type (2012-2017)

4.4 United States Iron Deficiency Anemia Drug Sales Growth Rate by Type (2012-2017)

5 United States Iron Deficiency Anemia Drug Sales (Volume) by Application (2012-2017)

5.1 United States Iron Deficiency Anemia Drug Sales and Market Share by Application (2012-2017)

5.2 United States Iron Deficiency Anemia Drug Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Iron Deficiency Anemia Drug Players/Suppliers Profiles and Sales Data

6.1 GlaxoSmithKline

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Iron Deficiency Anemia Drug Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 GlaxoSmithKline Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Bluebird bio

6.2.2 Iron Deficiency Anemia Drug Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Bluebird bio Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 GlycoMimetics

6.3.2 Iron Deficiency Anemia Drug Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 GlycoMimetics Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Mast Therapeutics

6.4.2 Iron Deficiency Anemia Drug Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Mast Therapeutics Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Bayer AG

6.5.2 Iron Deficiency Anemia Drug Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Bayer AG Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Eli Lilly

6.6.2 Iron Deficiency Anemia Drug Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Eli Lilly Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Acceleron Pharma

6.7.2 Iron Deficiency Anemia Drug Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Acceleron Pharma Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Regen biopharma

6.8.2 Iron Deficiency Anemia Drug Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Regen biopharma Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

7 Iron Deficiency Anemia Drug Manufacturing Cost Analysis

7.1 Iron Deficiency Anemia Drug Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Iron Deficiency Anemia Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Iron Deficiency Anemia Drug Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Iron Deficiency Anemia Drug Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Iron Deficiency Anemia Drug Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Iron Deficiency Anemia Drug Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Iron Deficiency Anemia Drug Sales Volume Forecast by Type (2017-2022)

11.3 United States Iron Deficiency Anemia Drug Sales Volume Forecast by Application (2017-2022)

11.4 United States Iron Deficiency Anemia Drug Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Iron Deficiency Anemia Drug

Figure United States Iron Deficiency Anemia Drug Market Size (K Pcs) by Type (2012-2022)

Figure United States Iron Deficiency Anemia Drug Sales Volume Market Share by Type (Product Category) in 2016

Figure Ferrous Sulfate (Feratab, Fer-Iron, Slow-FE) Product Picture

Figure Carbonyl Iron (Feosol) Product Picture

Figure Iron Dextran Complex (INFeD) Product Picture

Figure Iron Sucrose (Venofer) Product Picture

Figure Ferric Carboxymaltose (Injectafer) Product Picture

Figure United States Iron Deficiency Anemia Drug Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of Iron Deficiency Anemia Drug by Application in 2016

Figure Children Examples

Table Key Downstream Customer in Children

Figure Adult Examples

Table Key Downstream Customer in Adult

Figure The Old Examples

Table Key Downstream Customer in The Old

Figure United States Iron Deficiency Anemia Drug Market Size (Million USD) by Region (2012-2022)

Figure The West Iron Deficiency Anemia Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Iron Deficiency Anemia Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Iron Deficiency Anemia Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Iron Deficiency Anemia Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Iron Deficiency Anemia Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Iron Deficiency Anemia Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Iron Deficiency Anemia Drug Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States Iron Deficiency Anemia Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Iron Deficiency Anemia Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States Iron Deficiency Anemia Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States Iron Deficiency Anemia Drug Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Iron Deficiency Anemia Drug Sales Share by Players/Suppliers

Figure 2017 United States Iron Deficiency Anemia Drug Sales Share by Players/Suppliers

Figure United States Iron Deficiency Anemia Drug Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Iron Deficiency Anemia Drug Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Iron Deficiency Anemia Drug Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Iron Deficiency Anemia Drug Revenue Share by Players/Suppliers

Figure 2017 United States Iron Deficiency Anemia Drug Revenue Share by Players/Suppliers

Table United States Market Iron Deficiency Anemia Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market Iron Deficiency Anemia Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States Iron Deficiency Anemia Drug Market Share of Top 3 Players/Suppliers

Figure United States Iron Deficiency Anemia Drug Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Iron Deficiency Anemia Drug Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Iron Deficiency Anemia Drug Product Category

Table United States Iron Deficiency Anemia Drug Sales (K Pcs) by Region (2012-2017)

Table United States Iron Deficiency Anemia Drug Sales Share by Region (2012-2017)

Figure United States Iron Deficiency Anemia Drug Sales Share by Region (2012-2017)

Figure United States Iron Deficiency Anemia Drug Sales Market Share by Region in 2016

Table United States Iron Deficiency Anemia Drug Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Iron Deficiency Anemia Drug Revenue Share by Region (2012-2017)

Figure United States Iron Deficiency Anemia Drug Revenue Market Share by Region (2012-2017)

Figure United States Iron Deficiency Anemia Drug Revenue Market Share by Region in 2016

Table United States Iron Deficiency Anemia Drug Price (USD/Pcs) by Region (2012-2017)

Table United States Iron Deficiency Anemia Drug Sales (K Pcs) by Type (2012-2017)

Table United States Iron Deficiency Anemia Drug Sales Share by Type (2012-2017)

Figure United States Iron Deficiency Anemia Drug Sales Share by Type (2012-2017)

Figure United States Iron Deficiency Anemia Drug Sales Market Share by Type in 2016

Table United States Iron Deficiency Anemia Drug Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Iron Deficiency Anemia Drug Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Iron Deficiency Anemia Drug by Type (2012-2017)

Figure Revenue Market Share of Iron Deficiency Anemia Drug by Type in 2016

Table United States Iron Deficiency Anemia Drug Price (USD/Pcs) by Types (2012-2017)

Figure United States Iron Deficiency Anemia Drug Sales Growth Rate by Type (2012-2017)

Table United States Iron Deficiency Anemia Drug Sales (K Pcs) by Application (2012-2017)

Table United States Iron Deficiency Anemia Drug Sales Market Share by Application (2012-2017)

Figure United States Iron Deficiency Anemia Drug Sales Market Share by Application (2012-2017)

Figure United States Iron Deficiency Anemia Drug Sales Market Share by Application in 2016

Table United States Iron Deficiency Anemia Drug Sales Growth Rate by Application (2012-2017)

Figure United States Iron Deficiency Anemia Drug Sales Growth Rate by Application (2012-2017)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Iron Deficiency Anemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure GlaxoSmithKline Iron Deficiency Anemia Drug Sales Growth Rate (2012-2017)

Figure GlaxoSmithKline Iron Deficiency Anemia Drug Sales Market Share in United States (2012-2017)

Figure GlaxoSmithKline Iron Deficiency Anemia Drug Revenue Market Share in United States (2012-2017)

Table Bluebird bio Basic Information List

Table Bluebird bio Iron Deficiency Anemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Bluebird bio Iron Deficiency Anemia Drug Sales Growth Rate (2012-2017)

Figure Bluebird bio Iron Deficiency Anemia Drug Sales Market Share in United States (2012-2017)

Figure Bluebird bio Iron Deficiency Anemia Drug Revenue Market Share in United States (2012-2017)

Table GlycoMimetics Basic Information List

Table GlycoMimetics Iron Deficiency Anemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure GlycoMimetics Iron Deficiency Anemia Drug Sales Growth Rate (2012-2017)

Figure GlycoMimetics Iron Deficiency Anemia Drug Sales Market Share in United States (2012-2017)

Figure GlycoMimetics Iron Deficiency Anemia Drug Revenue Market Share in United States (2012-2017)

Table Mast Therapeutics Basic Information List

Table Mast Therapeutics Iron Deficiency Anemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Mast Therapeutics Iron Deficiency Anemia Drug Sales Growth Rate (2012-2017)

Figure Mast Therapeutics Iron Deficiency Anemia Drug Sales Market Share in United States (2012-2017)

Figure Mast Therapeutics Iron Deficiency Anemia Drug Revenue Market Share in United States (2012-2017)

Table Bayer AG Basic Information List

Table Bayer AG Iron Deficiency Anemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Bayer AG Iron Deficiency Anemia Drug Sales Growth Rate (2012-2017)

Figure Bayer AG Iron Deficiency Anemia Drug Sales Market Share in United States (2012-2017)

Figure Bayer AG Iron Deficiency Anemia Drug Revenue Market Share in United States (2012-2017)

Table Eli Lilly Basic Information List

Table Eli Lilly Iron Deficiency Anemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Eli Lilly Iron Deficiency Anemia Drug Sales Growth Rate (2012-2017)

Figure Eli Lilly Iron Deficiency Anemia Drug Sales Market Share in United States (2012-2017)

Figure Eli Lilly Iron Deficiency Anemia Drug Revenue Market Share in United States (2012-2017)

Table Acceleron Pharma Basic Information List

Table Acceleron Pharma Iron Deficiency Anemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Acceleron Pharma Iron Deficiency Anemia Drug Sales Growth Rate (2012-2017)

Figure Acceleron Pharma Iron Deficiency Anemia Drug Sales Market Share in United States (2012-2017)

Figure Acceleron Pharma Iron Deficiency Anemia Drug Revenue Market Share in United States (2012-2017)

Table Regen biopharma Basic Information List

Table Regen biopharma Iron Deficiency Anemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Regen biopharma Iron Deficiency Anemia Drug Sales Growth Rate (2012-2017)

Figure Regen biopharma Iron Deficiency Anemia Drug Sales Market Share in United States (2012-2017)

Figure Regen biopharma Iron Deficiency Anemia Drug Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Iron Deficiency Anemia Drug

Figure Manufacturing Process Analysis of Iron Deficiency Anemia Drug

Figure Iron Deficiency Anemia Drug Industrial Chain Analysis

Table Raw Materials Sources of Iron Deficiency Anemia Drug Major Players/Suppliers in 2016

Table Major Buyers of Iron Deficiency Anemia Drug

Table Distributors/Traders List

Figure United States Iron Deficiency Anemia Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Iron Deficiency Anemia Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Iron Deficiency Anemia Drug Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States Iron Deficiency Anemia Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Iron Deficiency Anemia Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Iron Deficiency Anemia Drug Sales Volume (K Pcs) Forecast by Type in 2022

Table United States Iron Deficiency Anemia Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Iron Deficiency Anemia Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Iron Deficiency Anemia Drug Sales Volume (K Pcs) Forecast by Application in 2022

Table United States Iron Deficiency Anemia Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States Iron Deficiency Anemia Drug Sales Volume Share Forecast by Region (2017-2022)

Figure United States Iron Deficiency Anemia Drug Sales Volume Share Forecast by Region (2017-2022)

Figure United States Iron Deficiency Anemia Drug Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources